Predictors of mental and physical quality of life in Huntington’s disease;Prädiktoren der psychischen und physischen Lebensqualität beim Morbus Huntington

Nervenarzt

Volumn 86, Issue 2, 2015, Pages 167-173

  Brugger, F ^a,b   Hepperger, C ^a   Hametner, E M ^a   Holl, A K ^c   Painold, A ^c   Schusterschitz, C ^d   Bonelli, R ^e   Holas, C ^a   Wenning, G K ^a   Poewe, W ^a   Seppi, K ^a  

^a Universitatsklinik fur Neurochirurgie Innsbruck   (Austria)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^e SIGMUND FREUD UNIVERSITY   (Austria)

Author keywords

CAG repeats; Depression; Functional capacity; Huntington s disease; Quality of life

Indexed keywords

ARTICLE; BECK DEPRESSION INVENTORY; HAMILTON DEPRESSION RATING SCALE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; QUALITY OF LIFE; SHORT FORM 36; UNIFIED HUNTINGTON DISEASE RATING SCALE; ADULT; AGE DISTRIBUTION; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; GERMANY; HEALTH STATUS INDICATOR; HUNTINGTON DISEASE; MENTAL DISORDERS; MIDDLE AGED; MOVEMENT DISORDERS; PROGNOSIS; PSYCHOLOGY; RISK ASSESSMENT; SEX RATIO; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; DEPRESSION; GERMANY; HEALTH STATUS INDICATORS; HUMANS; HUNTINGTON DISEASE; MENTAL DISORDERS; MIDDLE AGED; MOVEMENT DISORDERS; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; SEX DISTRIBUTION;

EID: 84922566817     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-014-4187-3     Document Type: Article

References (20)

1. Cardoso F, Seppi K, Mair KJ et al (2006) Seminar on choreas. Lancet Neurol 5:589–602
2. Devinsky O (1995) Outcome research in neurology: incorporating health-related quality of life. Ann Neurol 37:141–142
3. Orth M (2011) Observing Huntington’s disease: the European Huntington’s Disease Network’s REGISTRY. J Neurol Neurosurg Psychiatry 82:1409–1412
4. Huntington Study Group (1996) Unified Huntington’s Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord 11:136–142
5. Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292
6. Ware JE Jr (2000) SF-36 health survey update. Spine (Phila Pa 1976) 25:3130–3139
7. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483
8. Ware JE, Kosinski M (2001) Interpreting SF-36 summary health measures: a response. Qual Life Res 10:405–413
9. Ho AK, Robbins AO, Walters SJ et al (2004) Health-related quality of life in Huntington’s disease: a comparison of two generic instruments, SF-36 and SIP. Mov Disord 19:1341–1348
10. Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
11. Beck AT, Steer RA (1984) Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 40:1365–1367
12. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
13. o A (1996) What quality of life? The WHOQOL Group. World Health Organization Quality of Life Assessment. World Health Forum 17:354–356
14. Ho AK, Gilbert AS, Mason SL et al (2009) Health-related quality of life in Huntington’s disease: which factors matter most? Mov Disord 24:574–578
15. De SJ, Jones LA, Rickards H (2010) Validation of self-report depression rating scales in Huntington’s disease. Mov Disord 25:91–96
16. Helder DI, Kaptein AA, Kempen GM van et al (2001) Impact of Huntington’s disease on quality of life. Mov Disord 16:325–330
17. Ho AK, Robbins AO, Walters SJ et al (2004) Health-related quality of life in Huntington’s disease: a comparison of two generic instruments, SF-36 and SIP. Mov Disord 19:1341–1348
18. Ready RE, Mathews M, Leserman A, Paulsen JS (2008) Patient and caregiver quality of life in Huntington’s disease. Mov Disord 23:721–726
19. Walker FO (2007) Huntington’s disease. Lancet 369:218–228
20. Ho AK, Hocaoglu MB (2011) Impact of Huntington’s across the entire disease spectrum: the phases and stages of disease from the patient perspective. Clin Genet 80:235–239